First study | Second study | ||||||
Case no. | Clinicopathological pattern | Suspected drug | Time of study11-150 | Maximal SI observed | Time of study11-150 | Maximal SI observed | |
1 | Mixed | Erythromycin | 2 months | 3.9 | 6 months | 1.3 | |
2 | Hepatocellular | Cotrimoxazole | 2 months | 4.1 | 4 months | 3.2 | |
3 | Cholestatic | Pyritinol | 9 months | 44.5 | 10 months | 45.2 | |
4 | Cholestatic | Flucloxacillin | 3 months | 3.2 | 6 months | 3.1 | |
5 | Hepatocellular | Phenytoin | 2 months | 2.8 | 4 months | 2.2 |
↵11-150 Time between onset of symptoms and the study.